Literature DB >> 21696419

Recurrent anaplastic meningioma treated by sunitinib based on results from quantitative proteomics.

A Yoshikawa, M Nakada, S Ohtsuki, Y Hayashi, W Obuchi, Y Sato, C Ikeda, T Watanabe, Y Kawahara, T Hasegawa, H Sabit, D Kita, Y Hayashi, Y Nakanuma, T Terasaki, J I Hamada.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 21696419     DOI： 10.1111/j.1365-2990.2011.01197.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN： 0305-1846            Impact factor:   8.090


× No keyword cloud information.
  2 in total

1.  Pharmacokinetic assessment of efflux transport in sunitinib distribution to the brain.

Authors:  Rajneet K Oberoi; Rajendar K Mittapalli; William F Elmquist
Journal:  J Pharmacol Exp Ther       Date:  2013-10-10       Impact factor: 4.030

2.  A study protocol for quantitative targeted absolute proteomics (QTAP) by LC-MS/MS: application for inter-strain differences in protein expression levels of transporters, receptors, claudin-5, and marker proteins at the blood-brain barrier in ddY, FVB, and C57BL/6J mice.

Authors:  Yasuo Uchida; Masanori Tachikawa; Wataru Obuchi; Yutaro Hoshi; Yusuke Tomioka; Sumio Ohtsuki; Tetsuya Terasaki
Journal:  Fluids Barriers CNS       Date:  2013-06-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.